Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorPeking University First Hospital
About this trial
This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 18~70 years old
Suspected OSA based on symptoms such as snoring, waking at night, daytime sleepiness, or requiring OSA screening due to related conditions; or confirmed OSA patients referred for sleep monitoring or CPAP pressure titration.
Subjects are conscious, utterly independent in behavioral and cognitive ability, and able to answer questions independently;
The patients gave informed consent to the study and cooperated with relevant treatment and evaluation.
Disqualifiers
Age below 18 or above 70 years old
No symptoms suggestive of OSA and no need for OSA screening; or patients without confirmed OSA
lacking full independence in behavior and cognitive ability, unable to answer questions independently
Patients who did not give informed consent or were unwilling to cooperate with treatment and evaluation
Trial population
* Patients with sleep disorders other than sleep disorders and respiratory disorders; * Patients with severe mental diseases (such as schizophrenia, bipolar disorder, paranoid mental disorders, mental retardation associated with mental disorders, mental disorders caused by epilepsy, schizoaffective disorders) and personality disorders; * Patients who are taking sleep-affecting medication. ④ Unable to cooperate with the relevant psychological scales for depression, anxiety, personality, and others. ⑤ Patients who have previously used or are being treated with a non-invasive ventilator. ⑥ Other serious somatic diseases or other conditions that may affect ventilator treatment are unsuitable for enrollment as assessed by the investigator.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
continous positive airway pressure (CPAP)
Deviceusing CPAP to treat OSA
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: Obstructive sleep apnea (OSA)1 intervention
Group B: non-OSA0 interventions
Trial outcomes
Primary outcomes
1
Eysenck Personality Questionnaire (EPQ)
This study adopted the classic short form of the Eysenck Personality Questionnaire - Revised (EPQ-R Short Scale) to assess individual personality traits across four dimensions: Psychoticism (P), Extraversion (E), Neuroticism (N), and Lie Scale (L). Each dimension consists of 12 items, with scores ranging from 0 to 12. Higher scores indicate a stronger presence of the corresponding trait. For example, a higher score on Neuroticism reflects greater emotional instability, while a higher score on Extraversion suggests a more outgoing and active personality
Time frame
At baselineSecondary outcomes
1
continuous positive airway pressure (CPAP) compliance
downloading the data from the CPAP to assess average daily usage duration (in hours) and the number of days used per week. Good adherence is typically defined as using the CPAP device for at least 4 hours per night on 70% or more nights over the past 3 consecutive months.
Time frame
From CPAP initiation to the 3-month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov